Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Pediatr Infect Dis J. 2018 Apr;37(4):304–309. doi: 10.1097/INF.0000000000001831

Table 5.

Relationship between timing of cART initiation and serologic immunity among fully vaccinated PHIV children

Vaccine Serologic immunity1 N cART
initiated <12 months of age
N (%)
cART
initiated ≥ 12 months of age
N (%)
No cART
N (%)
P-value2

HBV Immune 23 15 (31.9) 7 (14.9) 1 (6.2) 0.049
Not immune 87 32 (68.1) 40 (85.1) 15 (93.8)

Tetanus3 Immune 54 24 (72.7) 25 (75.8) 5 (55.6) 0.521
Not immune 21 9 (27.3) 8 (24.2) 4 (44.4)

Hib Immune 56 27 (57.4) 22 (44.9) 7 (53.8) 0.489
Not immune 53 20 (42.6) 27 (55.1) 6 (46.2)

Measles Immune 77 33 (86.8) 33 (76.7) 11 (73.3) 0.405
Not immune 19 5 (13.2) 10 (23.3) 4 (26.7)

Rubella Immune 70 32 (84.2) 29 (67.4) 9 (60.0) 0.20
Not immune 26 6 (15.8) 14 (32.6) 6 (40.0)
1

Considered immune to disease as follows; hepatitis B titer ≥10 IU/L, tetanus titer ≥ 0.1 IU/mL, Hib titer ≥ 1.0 μg/mL, measles titer ≥ 0.120 IU/mL, rubella titer ≥ 10 IU/mL. Equivocal results considered non-immune for tetanus and Hib.

2

P- values obtained using Fisher’s exact test.

3

Missing one serologic result for tetanus.